CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $392,144
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-26 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-01-24 | LAMATTINA JOHN L Director | Grant or award | +10,844 | $4.38 | $47K | 31,376 |
| 2018-06-06 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-01-03 | LAMATTINA JOHN L Director | Grant or award | +9,169 | $5.18 | $47K | 20,532 |
| 2017-06-21 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-02-13 | LAMATTINA JOHN L Director | Grant or award | +11,363 | $4.18 | $47K | 11,363 |
| 2016-06-30 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2016-01-25 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +9,150 | 9,150 |
Page 1 of 1 · 8 trades